Witcher, Derrick R.

Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications

Theurl, I., Aigner, E., Theurl, M., Nairz, M., Seifert, M., Schroll, A., Sonnweber, T., Eberwein, L., Witcher, D. R., Murphy, A. T., et al. (2009) · Blood

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 421

Novel Ghrelin Assays Provide Evidence for Independent Regulation of Ghrelin Acylation and Secretion in Healthy Young Men

Liu, J., Prudom, C. E., Nass, R., Pezzoli, S. S., Oliveri, M. C., Johnson, M. L., Veldhuis, P., Gordon, D. A., Howard, A. D., Witcher, D. R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism

Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases

Cited by 248

Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB

Sonnweber, T., Nachbaur, D., Schroll, A., Nairz, M., Seifert, M., Demetz, E., Haschka, D., Mitterstiller, A.-M., Kleinsasser, A., Burtscher, M., et al. (2014) · Gut

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 145

High-fat diet causes iron deficiency via hepcidin-independent reduction of duodenal iron absorption

Sonnweber, T., Ress, C., Nairz, M., Theurl, I., Schroll, A., Murphy, A. T., Wroblewski, V., Witcher, D. R., Moser, P., Ebenbichler, C. F., et al. (2012) · The Journal of Nutritional Biochemistry

Iron Metabolism and DisordersTrace Elements in Health

Cited by 117

Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia

Theurl, I., Finkenstedt, A., Schroll, A., Nairz, M., Sonnweber, T., Bellmann‐Weiler, R., Theurl, M., Seifert, M., Wroblewski, V. J., Murphy, A. T., et al. (2010) · British Journal of Haematology

Iron Metabolism and DisordersGDF15 and Related Biomarkers

Cited by 72

A dual-monoclonal sandwich ELISA specific for hepcidin-25

Butterfield, A. M., Luan, P., Witcher, D. R., Manetta, J., Murphy, A. T., Wroblewski, V. J., & Konrad, R. J. (2010) · Clinical Chemistry

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 59

Influence of improved FcRn binding on the subcutaneous bioavailability of monoclonal antibodies in cynomolgus monkeys

Datta-Mannan, A., Witcher, D. R., Lu, J., & Wroblewski, V. J. (2012) · mAbs

Monoclonal and Polyclonal Antibodies ResearchBiosimilars and Bioanalytical Methods

Cited by 53

Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency

Finkenstedt, A., Bianchi, P., Theurl, I., Vogel, W., Witcher, D. R., Wroblewski, V. J., Murphy, A. T., Zanella, A., & Zoller, H. (2009) · British Journal of Haematology

Iron Metabolism and DisordersGDF15 and Related Biomarkers

Cited by 51

Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats

Theurl, M., Nairz, M., Schroll, A., Sonnweber, T., Asshoff, M., Haschka, D., Seifert, M., Willenbacher, W., Wilflingseder, D., Posch, W., et al. (2014) · Haematologica

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 42

LY2928057, An Antibody Targeting Ferroportin, Is a Potent Inhibitor Of Hepcidin Activity and Increases Iron Mobilization In Normal Cynomolgus Monkeys

Witcher, D. R., Leung, D., Hill, K. A., De Rosa, D. C., Xu, J., Manetta, J., Wroblewski, V. J., & Benschop, R. J. (2013) · Blood

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 29